GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (XSWX:LONNE) » Definitions » Price-to-Funds-From-Operations

Lonza Group (XSWX:LONNE) Price-to-Funds-From-Operations : (As of May. 01, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Lonza Group Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Lonza Group Business Description

Address
Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.